A model for rat paw edema. II. Analyses on the effect of the antagonists.
D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001920:Bradykinin / Q000037:antagonists & inhibitors; D001963:Bromelains / Q000494:pharmacology; D002219:Carbamates / Q000494:pharmacology; D002351:Carrageenan / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004195:Disease Models, Animal; D004487:Edema / Q000139:chemically induced* / Q000517:prevention & control; D006633:Histamine Antagonists; D006358:Hot Temperature; D007213:Indomethacin / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008433:Mathematics; D010643:Phenoxybenzamine / Q000494:pharmacology; D011095:Polyethylenes / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D012702:Serotonin Antagonists; D014309:Tripelennamine / Q000494:pharmacology
D000605:Amino Alcohols; D000893:Anti-Inflammatory Agents; D002219:Carbamates; D006633:Histamine Antagonists; D011095:Polyethylenes; D011725:Pyridines; D012702:Serotonin Antagonists; D010643:Phenoxybenzamine; D014309:Tripelennamine; D004295:Dihydroxyphenylalanine; D008238:Lysergic Acid Diethylamide; D002351:Carrageenan; D001963:Bromelains; D001920:Bradykinin; D007213:Indomethacin